Amelioration of Alzheimer's disease by neuroprotective effect of sulforaphane in animal model

Amyloid

Volumn 20, Issue 1, 2013, Pages 7-12

  Kim, Hyunjin Vincent ^a   Kim, Hye Yun ^a   Ehrlich, Hanna Y ^a,b   Choi, Seon Young ^a   Kim, Dong Jin ^a   Kim, YoungSoo ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b TUFTS UNIVERSITY   (United States)

Author keywords

Acute AD animal model; Alzheimer's disease; Amyloid ; Cell viability assay; Passive avoidance test; Reactive oxygen species; Sulforaphane; Y maze test

Indexed keywords

AMYLOID BETA PROTEIN; SULFORAPHANE; TRANSCRIPTION FACTOR NRF2;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; BROCCOLI; CELL PROTECTION; COGNITION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; MALE; MAZE TEST; MOUSE; NEUROPROTECTION; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANTIOXIDANTS; AVOIDANCE LEARNING; CELL LINE; COGNITION; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; HUMANS; MALE; MAZE LEARNING; MICE; MICE, INBRED ICR; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; THIOCYANATES;

EID: 84874159254     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2012.751367     Document Type: Article

References (37)

1. Markesbery WR. Oxidative stress hypothesis in Alzheimer's disease. Free Radical Bio Med 1997;23:134-47 (Pubitemid 27217017)
2. Frank B, Gupta S. A review of antioxidants and Alzheimer's disease. Ann Clin Psychiatry 2005;17:269-86 (Pubitemid 41780250)
3. Kim Y, Lee J H, Ryu J, Kim DJ. Multivalent & multifunctional ligands to beta-Amyloid. Curr Pharm Des 2009;15:637-58
4. Butterfield DA. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: Implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic Res 2002; 36:1307-13 (Pubitemid 35469517)
5. Choi S J, Kim M J, Heo H J, Hong B, Cho H Y, Kim Y J, Kim H K, et al. Ameliorating effect of Gardenia jasminoides extract on amyloid beta peptide-induced neuronal cell deficit. Mol Cell 2007;24:113-8 (Pubitemid 47554798)
6. LaFerla F M, Green K N, Oddo S. Intracellular amyloid-beta in Alzheimer's disease. Nat Rev Neurosci 2007;8:499-509
7. Sondag C M, Dhawan G, Combs CK. Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia. J Neuroinflammation 2009;6:1
8. Klein W L, Krafft G A, Finch CE. Targeting small Abeta oligomers: The solution to an Alzheimer's disease conundrum? Trends Neurosci 2001;24:219-24 (Pubitemid 32204378)
9. Lue L F, Kuo Y M, Roher A E, Brachova L, Shen Y, Sue L, Beach T, et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 1999; 155:853-62 (Pubitemid 29426831)
10. Butterfield D A, Drake J, Pocernich C, Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: Central role for amyloid beta-peptide. Trends Mol Med 2001;7:548-54 (Pubitemid 33127140)
11. Tabner B J, Turnbull S, El-Agnaf O, Allsop D. Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases. Curr Top Med Chem 2001;1:507-17
12. Wruck C J, Gotz M E, Herdegen T, Varoga D, Brandenburg LO, Pufe T. Kavalactones protect neural cells against amyloid beta peptide-induced neurotoxicity via extracellular signal-regulated kinase 1/2-dependent nuclear factor erythroid 2-related factor 2 activation. Mol Pharmacol 2008;73:1785-95 (Pubitemid 351724366)
13. Varadarajan S, Yatin S, Aksenova M, Butterfield DA. Review: Blzheimer's amyloid beta-peptide-Associated free radical oxidative stress and neurotoxicity. J Struct Biol 2000;130:184-208
14. Zhou C C, Poulton E J, Grun F, Bammler T K, Blumberg B, Thummel K E, Eaton DL. The dietary isothiocyanate sulforaphane is an antagonist of the human steroid and xenobiotic nuclear receptor. Mol Pharmacol 2007;71:220-9 (Pubitemid 46020992)
15. Balasubramanian S, Chew Y C, Eckert RL. Sulforaphane suppresses polycomb group protein level via a proteasome-dependent mechanism in skin cancer cells. Mol Pharmacol 2011;80:870-8
16. Scott O, Galicia-Connolly E, Adams D, Surette S, Vohra S, Yager JY. The safety of cruciferous plants in humans: B systematic review. J Biomed Biotechnol 2012;2012:503241
17. Park H M, Kim J A, Kwak MK. Protection against amyloid beta cytotoxicity by sulforaphane: Role of the proteasome. Arch Pharm Res 2009;32:109-15
18. Elbarbry F, Elrody N. Potential health benefits of sulforaphane: B review of the experimental, clinical and epidemiological evidences and underlying mechanisms. J Med Plants Res 2011;5:473-84
19. Fahey J W, Talalay P. Antioxidant functions of sulforaphane: B potent inducer of phase II detoxication enzymes. Food Chem Toxicol 1999;37:973-79 (Pubitemid 29481800)
20. Gan N, Wu Y C, Brunet M, Garrido C, Chung F L, Dai C, Mi L. Sulforaphane activates heat shock response and enhances proteasome activity through up-regulation of Hsp27. J Biol Chem 2010;285:35528-36
21. Heiss E, Herhaus C, Klimo K, Bartsch H, Gerhauser C. Nuclear factor kappa B is a molecular target for sulforaphane-mediated antiinflammatory mechanisms. J Biol Chem 2001;276:32008-15
22. Choi J W, Kim H Y, Jeon M, Kim D J, Kim Y. Efficient access to highly pure beta-Amyloid peptide by optimized solid-phase synthesis. Amyloid 2012;19:133-7
23. Kim Y S, Moss J A, Janda KD. Biological tuning of synthetic tactics in solid-phase synthesis: Bpplication to A beta(1-42). J Org Chem 2004;69:7776-8 (Pubitemid 39403374)
24. Maurice T, Lockhart B P, Privat A. Amnesia induced in mice by centrally administered beta-Amyloid peptides involves cholinergic dysfunction. Brain Res 1996;706:181-93 (Pubitemid 26048681)
25. Kim H Y, Kim Y, Han G, Kim DJ. Regulation of in vitro Abeta1-40 aggregation mediated by small molecules. J Alzheimers' Dis 2010;22:73-85
26. Harris Jr. In vitro fibrillogenesis of the amyloid beta 1-42 peptide: Cholesterol potentiation and aspirin inhibition. Micron 2002; 33:609-26 (Pubitemid 35426586)
27. Bryan K J, Lee H, Perry G, Smith M A, Casadesus G. Transgenic mouse models of Alzheimer's disease: Behavioral testing and considerations. In: Buccafusco J J, ed. Methods of behavior analysis in neuroscience. 2nd ed. Florida: Boca Raton; 2009:1-18
28. Yan J J, Cho J Y, Kim H S, Kim K L, Jung J S, Huh S O, Suh HW, et al. Protection against beta-Amyloid peptide toxicity in vivo with long-Term administration of ferulic acid. Br J Pharmacol 2001;133:89-96
29. Ader R, Moleman P, Weijnen JAW. Retention of a passive avoidance response as a function of intensity and duration of electric shock. Psychon Sci 1972;26:125-8
30. Khurana R, Coleman C, Ionescu-Zanetti C, Carter SA, Krishna V, Grover R K, Roy R, et al. Mechanism of thioflavin T binding to amyloid fibrils. J Struct Biol 2005; 151:229-38 (Pubitemid 41338730)
31. LeVine III H. Thioflavine T interaction with synthetic Alzheimer's disease beta-Amyloid peptides: Detection of amyloid aggregation in solution. Protein Sci 1993;2:404-10 (Pubitemid 23071288)
32. Jin Y, Wang M, Rosen R T, Ho CT. Thermal degradation of sulforaphane in aqueous solution. J Agric Food Chem 1999; 47:3121-3 (Pubitemid 29422001)
33. Van Eylen D, Oey I, Hendrickx M, Van Loey A. Kinetics of the stability of broccoli (Brassica oleracea Cv. Italica) myrosinase and isothiocyanates in broccoli juice during pressure/temperature treatments. J Agric Food Chem 2007;55: 2163-70 (Pubitemid 46556200)
34. Selkoe D J, Schenk D. Alzheimer's disease: Molecular understanding predicts amyloid-based therapeutics. Ann Rev Pharmacol Toxicol 2003;43:545-84 (Pubitemid 37372653)
35. Uttara B, Singh A V, Zamboni P, Mahajan RT. Oxidative stress and neurodegenerative diseases: B review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 2009;7:65-74
36. Tufekci K U, Civi Bayin E, Genc S, Genc K. The Nrf2/ARE pathway: B promising target to counteract mitochondrial dysfunction in Parkinson's disease. Parkinsons Dis 2011;2011:314082
37. Bergstrom P, Andersson H C, Gao Y, Karlsson J O, Nodin C, Anderson M F, Nilsson M, et al. Repeated transient sulforaphane stimulation in astrocytes leads to prolonged Nrf2-mediated gene expression and protection from superoxide-induced damage. Neuropharmacology 2011;60:343-53